General Information of the Compound
Compound ID |
CP0395490
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl]-4-[2-[2-[2-[2-[2-[2-[2-[2-[[4-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylcarbamoyl]phenyl]methoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxymethyl]benzamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C60H88N6O13
|
||||||||||||||||||
Molecular Weight |
1101.393
|
||||||||||||||||||
Canonical SMILES |
COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(cc3)C(=O)NCCCN3CCN(CC3)c3ccccc3OC)cc2)CC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C60H88N6O13/c1-69-57-11-5-3-9-55(57)65-29-25-63(26-30-65)23-7-21-61-59(67)53-17-13-51(14-18-53)49-78-47-45-76-43-41-74-39-37-72-35-33-71-34-36-73-38-40-75-42-44-77-46-48-79-50-52-15-19-54(20-16-52)60(68)62-22-8-24-64-27-31-66(32-28-64)56-10-4-6-12-58(56)70-2/h3-6,9-20H,7-8,21-50H2,1-2H3,(H,61,67)(H,62,68)
Show/Hide
|
||||||||||||||||||
InChIKey |
FKPUMTSFODZMAY-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Protein ID: PT01161, D(4) dopamine receptor